These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 30908754)

  • 1. Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery (DEPOSITION) study: Results of a pilot study.
    Habbab LM; Hussain S; Power P; Bashir S; Gao P; Semelhago L; VanHelder T; Parry D; Chu V; Lamy A
    J Card Surg; 2019 May; 34(5):305-311. PubMed ID: 30908754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical Use of Tranexamic Acid in Cardiac Surgery: A Meta-Analysis.
    Habbab LM; Semelhago L; Lamy A
    Thorac Cardiovasc Surg; 2020 Apr; 68(3):212-218. PubMed ID: 31170736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous versus topical tranexamic acid administration in primary total knee arthroplasty: a meta-analysis.
    Shin YS; Yoon JR; Lee HN; Park SH; Lee DH
    Knee Surg Sports Traumatol Arthrosc; 2017 Nov; 25(11):3585-3595. PubMed ID: 27417102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic intraoperative tranexamic acid administration and postoperative blood loss after transapical aortic valve implantation.
    Madershahian N; Scherner M; Pfister R; Rudolph T; Deppe AC; Slottosch I; Kuhn E; Choi YH; Wahlers T
    J Cardiothorac Surg; 2015 Mar; 10():45. PubMed ID: 25888231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of tranexamic acid in paediatric cardiac surgery: study protocol for a double-blind randomised controlled trial.
    Zhang Y; Jia Y; Shi J; Yuan S; Wang R; Zhang Z; Wang X; Liu J; Ran J; Zhao Y; Hua Z; Yan J; Li S; Zheng Z; Hu S; Wang Y; Yan F
    BMJ Open; 2019 Nov; 9(11):e032642. PubMed ID: 31772102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome impact of different tranexamic acid regimens in cardiac surgery with cardiopulmonary bypass (OPTIMAL): Rationale, design, and study protocol of a multicenter randomized controlled trial.
    Shi J; Zhou C; Liu S; Sun H; Wang Y; Yan F; Pan W; Zheng Z
    Am Heart J; 2020 Apr; 222():147-156. PubMed ID: 32062173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous vs Topical Tranexamic Acid in Total Knee Arthroplasty Without Tourniquet Application: A Randomized Controlled Study.
    Tzatzairis TK; Drosos GI; Kotsios SE; Ververidis AN; Vogiatzaki TD; Kazakos KI
    J Arthroplasty; 2016 Nov; 31(11):2465-2470. PubMed ID: 27267228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial of Intravenous Combined with Topical Versus Single-Dose Intravenous Administration.
    Yi Z; Bin S; Jing Y; Zongke Z; Pengde K; Fuxing P
    J Bone Joint Surg Am; 2016 Jun; 98(12):983-91. PubMed ID: 27307358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous tranexamic acid reduces blood loss and transfusion requirements after periacetabular osteotomy.
    Levack AE; McLawhorn AS; Dodwell E; DelPizzo K; Nguyen J; Sink E
    Bone Joint J; 2020 Sep; 102-B(9):1151-1157. PubMed ID: 32862676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peri-articular tranexamic acid injection in total knee arthroplasty: a randomized controlled trial.
    Pinsornsak P; Rojanavijitkul S; Chumchuen S
    BMC Musculoskelet Disord; 2016 Jul; 17():313. PubMed ID: 27455842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose tranexamic acid for reducing bleeding and transfusions in total hip arthroplasty: A double-blind, randomized controlled trial of different doses.
    Wang C; Kang P; Ma J; Yue C; Xie J; Pei F
    Thromb Res; 2016 May; 141():119-23. PubMed ID: 27016618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Most Effective Regimen of Tranexamic Acid for Reducing Bleeding and Transfusions in Primary Total Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials.
    Dai WL; Zhou AG; Zhang H; Zhang J
    J Knee Surg; 2018 Aug; 31(7):654-663. PubMed ID: 28895645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Administration of Systemic and Topical Tranexamic Acid for Total Knee Arthroplasty: Can It Be a Better Regimen and Yet Safe? A Randomized Controlled Trial.
    Jain NP; Nisthane PP; Shah NA
    J Arthroplasty; 2016 Feb; 31(2):542-7. PubMed ID: 26507526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Intra-Articular and Intravenous Tranexamic Acid Reduces Blood Loss in Total Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Nielsen CS; Jans Ø; Ørsnes T; Foss NB; Troelsen A; Husted H
    J Bone Joint Surg Am; 2016 May; 98(10):835-41. PubMed ID: 27194493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical tranexamic acid in hip fractures: a randomized, placebo-controlled double-blinded study.
    Costain D; Elder G; Fraser B; Slagel B; Kelly A; Cheong Y; Fera L
    Can J Surg; 2021 Aug; 64(4):E449-E456. PubMed ID: 34388107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intra-Articular Application of Tranexamic Acid Significantly Reduces Blood Loss and Transfusion Requirement in Primary Total Knee Arthroplasty].
    Lošťák J; Gallo J; Špička J; Langová K
    Acta Chir Orthop Traumatol Cech; 2016; 83(4):254-262. PubMed ID: 28026726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial.
    Bradley KE; Ryan SP; Penrose CT; Grant SA; Wellman SS; Attarian DE; Green CL; Risoli T; Bolognesi MP
    Bone Joint J; 2019 Sep; 101-B(9):1093-1099. PubMed ID: 31474134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local Application of Tranexamic Acid in Total Hip Arthroplasty Decreases Blood Loss and Consumption of Blood Transfusion].
    Lošťák J; Gallo J; Večeřa M; Špička J; Langová K
    Acta Chir Orthop Traumatol Cech; 2017; 84(4):254-262. PubMed ID: 28933328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Combined with Topical Administration of Tranexamic Acid in Primary Total Hip Arthroplasty: A Randomized Controlled Trial.
    Zeng Y; Si HB; Shen B; Yang J; Zhou ZK; Kang PD; Pei FX
    Orthop Surg; 2017 May; 9(2):174-179. PubMed ID: 28093896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.
    Vonk AB; Meesters MI; Schats J; Romijn JW; Jansen EK; Boer C
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):135-9. PubMed ID: 21075830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.